Bladder Cancer: Diagnosis and Clinical Management

Bladder Cancer: Diagnosis and Clinical Management is a 100% clinically–focused guide to bladder cancer, providing practical, modern and evidence–based guidance to the latest in diagnosis and management of the condition.  It differs from other books in its complete clinical focus as opposed to a heavy analysis of pathogenesis or basic science.  As a result, practicing urologists and oncologists in the clinical setting will find it an essential resource to consult.  In addition to the latest in diagnostic tools and imaging methods, core focus is on the management of each form of cancer at its various stages.  Both drug therapies and the range of surgical options are covered, ensuring that this is the perfect tool for clinicians to consult when considering which type of management program is appropriate for each individual patient.  A key addition is the final section dedicated to optimizing health care delivery, featuring chapters on highly topical issues such as quality of life, patient advocacy and surgical education.  Full color throughout, and packed with excellent images, each chapter contains concise and didactic practical tips and tricks to enrich the reading experience, in addition to management algorithms and the very latest guidelines from the ASCO, AUA, ESMO and EAU concerning clinical management of bladder cancer. INDICE: Part I: Diagnosis and Treatment of Non–Muscle Invasive Bladder Cancer .1 Pathology Hikmat Al–Ahmadie and Donna E. Hansel .2 Risk Stratification of High–grade Ta, Cis and T1 Urothelial Carcinoma of the Bladder Tobias Klatte, Fred Witjes, Gary Steinberg, and Shahrokh F. Shariat .3 Utility of Urine Biomarkers Derya Tilki and Alexandre R. Zlotta .4 Novel Endoscopic Techniques for the Detection of Bladder Cancer Ayman Soubra, Joseph C. Liao and Badrinath Konety .5 Transurethral Resection of Bladder Tumors Jen–Jane Liu and Mark P. Schoenberg .6 Intravesical Chemotherapy Levent N. Türkeri, M. Guillaume Wientjes, and Jessie L.S. Au .7 Intravesical Immunotherapy Nilay M. Gandhi, Laura A. Bertrand, Donald L. Lamm, and Michael A. O Donnell .8 HGT1 Bladder Cancer: Diagnosis and Treatment J.M. Gaya, J. Palou, and Edward M. Messing .9 What To Do When Bacillus Calmette–Guerin Fails Massimiliano Spaliviero, Guido Dalbagni, and Matthew Nielsen .Part II: T2–4 .10 Selection and Peri–operative Management of Patients Undergoing Radical Cystectomy and Urinary Reconstruction Robert S. Svatek and Alon Z. Weizer .11 Radical Cystectomy: Techniques and Outcomes Siamak Daneshmand and Seth P. Lerner .12 Cystectomy in the Female Patient Ryan Werntz, Georgios Gakis, Theresa Koppie, and Arnulf Stenzl .13 Laparoscopic/Robotic Radical Cystectomy and Urinary Diversion: Outcomes Kristina Wittig, Kevin Chan, Mark Kawachi, and Timothy G. Wilson .14 Robotic Assisted Radical Cystectomy and Urinary Diversion: Clinical Trials George J.S. Kallingal, Angela B. Smith, Raj S. Pruthi, and Dipen J. Parekh .15 Role of Extended Lymphadenectomy Eugene K. Cha, George N. Thalmann, and Bernard H. Bochner .16 Management of the Urethra in the Cystectomy Patient Kamal S. Pohar and Norm D. Smith .17 The Role of Radical Cystectomy in Patients with Unresectable or Regionally Metastatic Urothelial Carcinoma of the Bladder Scott Delacroix, Jr, Nathan Lawrentschuk, and Ashish M. Kamat .Part III: Primary Bladder Sparing Therapy .18 Radical Transurethral Resection Eduardo Solsona and Harry W. Herr .19 Partial Cystectomy Ahmed Haddad, Yair Lotan, and Arthur I. Sagalowsky .20 Integrating Chemotherapy and Radiotherapy for Bladder Cancer Lior Z. Braunstein, William U. Shipley, Nicholas D. James, Andrea B. Apolo, and Jason A. Efstathiou .Part IV: Urinary Tract Reconstruction .21 Orthotopic Neobladder Eila C. Skinner .22 Continent Cutaneous Diversion Andreas Neisius and Joachim W. Thüroff .23 Non–continent Urinary Diversion Michael Rink, Fredrik Liedberg, and Margit Fisch .Part V: Treatment of Regionally Advanced and Metastatic Bladder Cancer .24 Molecular Determinants of Chemotherapy Response Matthew I. Milowsky, Peter H. O Donnell, Thomas W. Flaig, and Dan Theodorescu .25 Neo–adjuvant Chemotherapy in the Treatment of Muscle–invasive Bladder Cancer David I. Quinn and Cora N. Sternberg .26 Adjuvant Chemotherapy for Invasive Bladder Cancer André P. Fay, Jeffrey J. Leow, and Joaquim Bellmunt .27 Treatment of Metastatic Bladder Cancer Gopa Iyer, Fabio Calabró, and Dean F. Bajorin .28 Treatment of Poor Risk Patients Maria De Santis and Matthew D. Galsky .Part VI: Genomics and the Current Status of Urothelial Cancer .29 Molecular Events in Muscle–invasive Bladder Cancer Development Jonathan Rosenberg, William Y. Kim, Jaegil Kim, and David J. Kwiatkowski .30 Cancer Stem Cells and Intrinsic Subtypes in Bladder Cancer Keith Syson Chan and David J. McConkey .31 Multi–targeted Agents in Treatment of Urothelial Carcinoma Noah M. Hahn, Colin P.N. Dinney, and Guru Sonpavde .Part VII: Optimizing Health Care Delivery .32 Patient Navigation and Cancer Navigator Programs Scott M. Gilbert and Michael Porter .33 Impact of Health Services on Compliance and Outcomes Heather Honoré Goltz, Marc A. Kowalkowski, G. John Chen, and David M. Latini .34 Quality of Life and Survivorship Nihal E. Mohamed and Cheryl T. Lee .35 Bladder Cancer: Health Care Delivery and Third Party Payers Seth A. Strope and John L. Gore .36 Bladder Cancer Patient Advocacy: Creating Partnerships to Advance Patient Care, Research, and Clinical Trials Diane Zipursky Quale and Rick Bangs

• ISBN: 978-1-118-67484-0
• Editorial: Wiley–Blackwell
• Encuadernacion: Cartoné
• Páginas: 464
• Fecha Publicación: 14/08/2015
• Nº Volúmenes: 1
• Idioma: Inglés